Evaluation of FGFR1 as a diagnostic biomarker for ovarian cancer using TCGA and GEO datasets.
Xiao H, Wang K, Li D, Wang K, Yu M.
PeerJ. 2021 Feb 3;9:e10817. doi: 10.7717/peerj.10817. eCollection 2021.
FGFR1 SUMOylation coordinates endothelial angiogenic signaling in angiogenesis.
Zhu X, Qiu C, Wang Y, Jiang Y, Chen Y, Fan L, Ren R, Wang Y, Chen Y, Feng Y, Zhou X, Zhu Y, Ge Z, Lai D, Qin L, Simons M, Yu L.
Proc Natl Acad Sci U S A. 2022 Jun 28;119(26):e2202631119. doi: 10.1073/pnas.2202631119. Epub 2022 Jun 21.
Nuclear FGFR1 Regulates Gene Transcription and Promotes Antiestrogen Resistance in ER(+) Breast Cancer.
Servetto A, Kollipara R, Formisano L, Lin CC, Lee KM, Sudhan DR, Gonzalez-Ericsson PI, Chatterjee S, Guerrero-Zotano A, Mendiratta S, Akamatsu H, James N, Bianco R, Hanker AB, Kittler R, Arteaga CL.
Clin Cancer Res. 2021 Aug 1;27(15):4379-4396. doi: 10.1158/1078-0432.CCR-20-3905. Epub 2021 May 19.
Myeloid neoplasms associated with eosinophilia and rearrangement of PDGFRA, PDGFRB, and FGFR1: a review.
Savage N, George TI, Gotlib J.
Int J Lab Hematol. 2013 Oct;35(5):491-500. doi: 10.1111/ijlh.12057. Epub 2013 Mar 13.
Myeloid neoplasms with eosinophilia.
Reiter A, Gotlib J.
Blood. 2017 Feb 9;129(6):704-714. doi: 10.1182/blood-2016-10-695973. Epub 2016 Dec 27.
Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB or FGFR1.
Bain BJ.
Haematologica. 2010 May;95(5):696-8. doi: 10.3324/haematol.2009.021675.
FGFR1-Related Hartsfield Syndrome.
Dhamija R, Babovic-Vuksanovic D.
2016 Mar 3 [updated 2022 May 12]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2024.
A novel FGFR1 inhibitor CYY292 suppresses tumor progression, invasion, and metastasis of glioblastoma by inhibiting the Akt/GSK3beta/snail signaling axis.
Bi Y, Zheng R, Hu J, Shi R, Shi J, Wang Y, Wang P, Jiang W, Kim G, Liu Z, Li X, Lin L.
Genes Dis. 2023 Apr 3;11(1):479-494. doi: 10.1016/j.gendis.2023.02.035. eCollection 2024 Jan.
Eosinophilic myeloid disorders.
Noel P.
Semin Hematol. 2012 Apr;49(2):120-7. doi: 10.1053/j.seminhematol.2012.01.008.
The D647N mutation of FGFR1 induces ligand-independent receptor activation.
Domenichini M, Ravelli C, Corsini M, Codenotti S, Moreschi E, Gogna A, Capoferri D, Zizioli D, Bresciani R, Grillo E, Mitola S.
Biochim Biophys Acta Gen Subj. 2023 Dec;1867(12):130470. doi: 10.1016/j.bbagen.2023.130470. Epub 2023 Sep 29.
